ALHAMBRA, Calif., April 2,
2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana,"
and together with its subsidiaries and affiliated entities, the
"Company") (NASDAQ: ASTH), a leading provider-centric,
technology-powered healthcare company enabling providers to deliver
accessible, high-quality, and high-value care to all, today
announced that effective on March 29,
2024, the Compensation Committee of Astrana's Board of
Directors (the "Committee") granted a total of 16,874 shares of
restricted common stock to two newly-hired non-executive employees,
under the Astrana Health, Inc. Employment Inducement Award Plan
(the "Inducement Plan"). In addition, the Company previously
disclosed on December 18, 2023 that
it granted a total of 38,779 shares of restricted common stock to
eight newly-hired non-executive employees, when the Company granted
a total of 40,459 shares of restricted common stock to such
employees. The Inducement Plan is used exclusively for the grant of
equity awards to individuals who were not previously an employee or
non-employee director of the Company (or who are re-employed
following a bona fide period of non-employment) as an inducement
material to such individuals' commencement of employment with the
Company, in accordance with Nasdaq Listing Rule 5635(c)(4).
5,189 of the shares of restricted stock will vest, subject to
continued employment, over four years in substantially equal annual
installments on the first, second, third and fourth anniversaries
of the grant date. 11,685 of the shares of restricted stock will
vest, subject to continued employment and the achievement of
applicable performance goals, in substantially equal semi-annual
installments over the four-year period ending on January 1, 2028. The restricted stock awards are
subject to the terms and conditions of the Inducement Plan and an
award agreement covering the grant.
About Astrana Health, Inc.
Astrana is a leading provider-centric, technology-powered
healthcare company enabling providers to deliver accessible,
high-quality, and high-value care to all. Leveraging its
proprietary end-to-end technology solutions, Astrana operates an
integrated healthcare delivery platform that enables providers to
successfully participate in value-based care arrangements, thus
empowering them to deliver high quality care to patients in a
cost-effective manner.
Headquartered in Alhambra,
California, Astrana serves over 10,000 providers and 900,000
Americans in value-based care arrangements. Its subsidiaries and
affiliates include management services organizations (MSOs),
affiliated independent practice associations (IPAs), accountable
care organizations (ACOs), and care delivery entities across
primary, multi-specialty, and ancillary care. For more information,
please visit www.astranahealth.com.
FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
investors@astranahealth.com
Asher Dewhurst, ICR Westwicke
investors@astranahealth.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-announces-grant-of-inducement-awards-pursuant-to-nasdaq-listing-rule-5635c4-302106257.html
SOURCE Astrana Health, Inc.